Managers / Q1 2023 · view latest →
HARBOURVEST PARTNERS LLC
CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707
Reported Value
$297M
Q1 2023
Positions
63
Filings on Record
32
2019–present window
Filed
May 15, 2023
original filing
Summary
Harbourvest Partners LLC reported $297M in U.S.-listed holdings across 63 positions for Q1 2023.
Its largest position, NABL, represents 16.5% of the portfolio.
Compared with Q4 2022, the fund opened 7 new positions and exited 9.
Portfolio Metrics
Turnover
+29.7%
vs prior filed quarter
Top-10 Concentration
+78.9%
share of reported value
Largest Position
+16.5%
N Able
New / Exited
7 / 9
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 81.6% · $242M
- Other · 12.8% · $38M
- ADR · 5.6% · $17M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Solarwinds Corp. | NEW | +3.72M | 3.72M | +$32M | $32M |
| HSAIHesai Group | NEW | +606.1K | 606.1K | +$9M | $9M |
| HashiCorp, Inc. | NEW | +228.7K | 228.7K | +$7M | $7M |
| Hammerhead Energy Inc. | NEW | +716.9K | 716.9K | +$6M | $6M |
| Tim Hortons China | NEW | +596.9K | 596.9K | +$2M | $2M |
| VYGRVoyager Therapeutics, Inc. | NEW | +61.8K | 61.8K | +$476,293 | $476,293 |
| RYTMRhythm Pharmaceuticals, Inc. | NEW | +5.6K | 5.6K | +$100,600 | $100,600 |
| Solarwinds Corp. | SOLD OUT | −3.72M | 0 | −$35M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
63 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | NABLN-Able, Inc.history → | Common | 16.54% | $49M | 3.72M |
| 2 | TOSTToast, Inc.history → | Common CLA | 13.65% | $41M | 2.28M |
| 3 | WWayfair Inc.history → | Common CLA | 12.28% | $36M | 1.06M |
| 4 | Solarwinds Corp. | Common | 10.77% | $32M | 3.72M |
| 5 | MNDYmonday.com Ltd.history → | SHS | 8.75% | $26M | 182.0K |
| 6 | Omega Therapeutics, Inc. | Common | 7.13% | $21M | 3.51M |
| 7 | HSAIHesai Grouphistory → | Sponsored ADS | 3.16% | $9M | 606.1K |
| 8 | YMMFull Truck Alliance Co. Ltd.history → | ADR | 2.45% | $7M | 957.6K |
| 9 | HashiCorp, Inc. | Common CLA | 2.26% | $7M | 228.7K |
| 10 | Hammerhead Energy Inc. | Common CLA | 1.87% | $6M | 716.9K |
| 11 | RLAYRelay Therapeutics, Inc.history → | Common | 1.64% | $5M | 296.4K |
| 12 | IASIntegral Ad Science, Inc.history → | Common | 1.47% | $4M | 305.3K |
| 13 | LendingClub Corp. | Common | 1.25% | $4M | 513.4K |
| 14 | Sonder Holdings, Inc. | Common CLA | 1.15% | $3M | 4.50M |
| 15 | BEBloom Energy Corporationhistory → | Common CLA | 1.09% | $3M | 162.2K |
| 16 | Axcella Health, Inc. | Common | 1.00% | $3M | 6.21M |
| 17 | Tim Hortons China | Ordinary Shares | 0.82% | $2M | 596.9K |
| 18 | Inari Medical | Common | 0.80% | $2M | 38.5K |
| 19 | SPOTSpotify Technology S.A. | SHS | 0.75% | $2M | 16.8K |
| 20 | FTCHQFarfetch Ltd. | Ordinary Shares CLA | 0.73% | $2M | 442.7K |
| 21 | COURCoursera, Inc. | Common | 0.67% | $2M | 172.2K |
| 22 | AMPLAmplitude Inc. | Common CLA | 0.64% | $2M | 153.0K |
| 23 | ACVAACV Auctions, Inc. | Common CLA | 0.64% | $2M | 147.1K |
| 24 | DOCNDigital Ocean, Inc. | Common | 0.58% | $2M | 44.2K |
| 25 | Zuora, Inc. | Common | 0.55% | $2M | 163.9K |
| 26 | DOCSDoximity, Inc. | Common CLA | 0.54% | $2M | 49.8K |
| 27 | Olo, Inc. | Common CLA | 0.52% | $2M | 188.3K |
| 28 | Sumo Logic, Inc. | Common | 0.52% | $2M | 127.8K |
| 29 | FROGJfrog Ltd. | ORD SHS | 0.39% | $1M | 59.0K |
| 30 | PATHUiPath, Inc. | Common CLA | 0.38% | $1M | 63.7K |
| 31 | UUnity Software | Common | 0.37% | $1M | 34.2K |
| 32 | PGNYProgyny, Inc. | Common | 0.34% | $1M | 31.9K |
| 33 | TWLOTwilio, Inc. | Common CLA | 0.33% | $970,932 | 14.6K |
| 34 | ONTFON24, Inc. | Common | 0.32% | $956,680 | 109.2K |
| 35 | GTMZoom Information, Inc | Common | 0.32% | $956,104 | 38.7K |
| 36 | Bright Health Group, Inc. | Common | 0.31% | $929,163 | 4.22M |
| 37 | Eventbrite, Inc. | Common CLA | 0.30% | $876,567 | 102.2K |
| 38 | HNSTThe Honest Company Inc. | Common | 0.29% | $856,132 | 475.6K |
| 39 | DIBS1stdibs.com, Inc. | Common | 0.27% | $791,999 | 199.5K |
| 40 | Sigilon Therapeutics, Inc. | Common | 0.23% | $688,962 | 740.7K |
| 41 | IBRXImmunityBio, Inc. | Common | 0.21% | $610,990 | 335.7K |
| 42 | PINSPinterest, Inc. | Common CLA | 0.20% | $581,124 | 21.3K |
| 43 | SMRTSmartRent.com | Common CLA | 0.19% | $561,811 | 220.3K |
| 44 | Evelo Biosciences, Inc. | Common | 0.19% | $553,575 | 3.06M |
| 45 | HOODRobinhood Markets Inc. | Common CLA | 0.17% | $492,151 | 50.7K |
| 46 | VYGRVoyager Therapeutics, Inc. | Common | 0.16% | $476,293 | 61.8K |
| 47 | CPNGCoupang Inc. | Common CLA | 0.14% | $429,344 | 26.8K |
| 48 | Seres Therapeutics, Inc. | Common | 0.09% | $279,888 | 49.4K |
| 49 | PACBPacific Biosciences of California, Inc. | Common | 0.09% | $271,945 | 23.5K |
| 50 | AFRMAffirm, Inc. | Common CLA | 0.09% | $261,577 | 23.2K |
| 51 | QSQuantumScape Corporation | Common CLA | 0.08% | $236,819 | 29.0K |
| 52 | DASHDoorDash, Inc. | Common CLA | 0.05% | $159,218 | 2.5K |
| 53 | Rallybio Holdings, LLC | Common | 0.04% | $124,918 | 21.9K |
| 54 | RPTXRepare Therapeutics, Inc. | Common | 0.04% | $120,796 | 12.3K |
| 55 | IPSCCentury Therapeutics, Inc. | Common | 0.03% | $100,692 | 29.0K |
| 56 | RYTMRhythm Pharmaceuticals, Inc. | Common | 0.03% | $100,600 | 5.6K |
| 57 | OPENOpendoor Technologies Inc. | Common | 0.03% | $82,204 | 46.7K |
| 58 | Astra Space, Inc. | Common CLA | 0.03% | $79,333 | 186.7K |
| 59 | Spark Networks SE | Sponsored ADR | 0.02% | $69,833 | 104.2K |
| 60 | PMVPPMV Pharmaceuticals | Common | 0.02% | $55,012 | 11.5K |
| 61 | GreenLight Biosciences, Inc. | Common | 0.01% | $21,097 | 48.8K |
| 62 | Aligos Therapeutics, Inc. | Common | 0.01% | $16,416 | 18.8K |
| 63 | NextCure, Inc. | Common | 0.01% | $14,865 | 10.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $101M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 7 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $205M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $91M | 15 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $154M | 16 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $203M | 22 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $192M | 34 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $188M | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $219M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $299M | 53 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $295M | 58 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $352M | 60 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $297M | 63 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $299M | 65 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $306M | 67 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $305M | 62 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $490M | 66 | May 26, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2021 | $782M | 67 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.0B | 51 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $746M | 44 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $256M | 26 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $270M | 36 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $232M | 28 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $207M | 36 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $243M | 35 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $240M | 33 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $262M | 32 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $283M | 33 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $211M | 32 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.